Summary for 8VSG
Entry DOI | 10.2210/pdb8vsg/pdb |
Descriptor | 3C-like proteinase nsp5, 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, (1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-(1-phenylcyclopropane-1-carbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide, ... (6 entities in total) |
Functional Keywords | covalent inhibitor, protease, coronavirus, antiviral, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 2 |
Total formula weight | 69879.29 |
Authors | |
Primary citation | Carney, D.W.,Leffler, A.E.,Bell, J.A.,Chandrasinghe, A.S.,Cheng, C.,Chang, E.,Dornford, A.,Dougan, D.R.,Frye, L.L.,Grimes, M.E.,Knehans, T.,Knight, J.L.,Komandla, M.,Lane, W.,Li, H.,Newman, S.R.,Phimister, K.,Saikatendu, K.S.,Silverstein, H.,Vafaei, S. Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity. Bioorg.Med.Chem., 103:117577-117577, 2024 Cited by PubMed: 38518735DOI: 10.1016/j.bmc.2023.117577 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.071 Å) |
Structure validation
Download full validation report